1. Home
  2. ERO vs SUPN Comparison

ERO vs SUPN Comparison

Compare ERO & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ero Copper Corp.

ERO

Ero Copper Corp.

HOLD

Current Price

$27.79

Market Cap

3.2B

Sector

N/A

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$53.82

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ERO
SUPN
Founded
2016
2005
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
ERO
SUPN
Price
$27.79
$53.82
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$32.50
$61.60
AVG Volume (30 Days)
1.5M
748.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$392,755,000.00
Revenue This Year
$65.83
$23.19
Revenue Next Year
$54.77
$17.65
P/E Ratio
$22.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.30
$29.16
52 Week High
$39.80
$59.68

Technical Indicators

Market Signals
Indicator
ERO
SUPN
Relative Strength Index (RSI) 38.04 55.71
Support Level $19.89 $47.95
Resistance Level $35.64 $58.67
Average True Range (ATR) 1.75 2.33
MACD -0.48 0.13
Stochastic Oscillator 5.14 41.87

Price Performance

Historical Comparison
ERO
SUPN

About ERO Ero Copper Corp.

Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: